Chitosan-derived biomaterials
US5747475A · kind A · utility
63Cited by
17References
19Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 2, 1996 |
| Grant date | May 5, 1998 |
| Priority date | — |
| Expiry date | Oct 2, 2016 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC08L5/08
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Chitosan-derived biomaterials, and, more specifically, chitosan modified by the addition of a monosaccharide or oligosaccharide side chain to its free amino groups. The modified chitosan ("glycated chitosan") is preferably stabilized by reduction. In one particularly preferred embodiment, a galactose derivative of chitosan ("galacto-chitosan") is provided. The chitosan-derived biomaterials are useful in a myriad of biomedical applications, including as an immunoadjuvant in laser/sensitizer assisted immunotherapy.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.